A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...

The FDA said that the amount of imported food products has increased through years — from more than 400,000 batches imported ...

Elsa” is the FDA’s new anthropomorphized AI tool which, the FDA hopes, will speed up clearances, licenses, and approvals ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

The solution automatically labels subdural collections and reports measurements such as thickness, midline shift, and volume.